Showing results (21-30 of 264) with videos related to
Sort By:
Pageof 27
Nature Reviews. Drug Discovery|March 2, 2013
Targeting pathological B cell receptor signalling in lymphoid malignanciesRyan M Young, Louis M StaudtCancer Cell|July 16, 2014
Ibrutinib treatment of CLL: the cancer fights backRyan M Young, Louis M StaudtCurrent Opinion in Hematology|June 4, 2002
Molecular diagnosis of lymphoid malignancies by gene expression profilingR Eric Davis, Louis M StaudtCancer Research|December 1, 2018
TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by IbrutinibEman L Dadashian, Erin M McAuley, Delong Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|January 21, 2016
Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1Joseph D Dekker, Daechan Park, Arthur L Shaffer, et al.Proceedings of the National Academy of Sciences of the United States of America|March 5, 2020
Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14Jaewoo Choi, James D Phelan, George W Wright, et al.Blood|April 16, 2016
Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphomaMark Roschewski, Louis M Staudt, Wyndham H WilsonImmunological Reviews|March 23, 2012
Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignanciesKian-Huat Lim, Yibin Yang, Louis M StaudtNature Reviews. Immunology|December 4, 2002
Lymphoid malignancies: the dark side of B-cell differentiationA L Shaffer, Andreas Rosenwald, Louis M StaudtNature Reviews. Clinical Oncology|November 13, 2013
Diffuse large B-cell lymphoma-treatment approaches in the molecular eraMark Roschewski, Louis M Staudt, Wyndham H WilsonPageof 27